Victrex plc (LON:VCT) Insider Martin Court Purchases 10 Shares of Stock

Victrex plc (LON:VCT – Get Free Report) insider Martin Court purchased 10 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The shares were acquired at an average cost of GBX 1,507 ($19.70) per share, with a total value of £150.70 ($197.04).

Martin Court also recently made the following trade(s):

Get Victrex alerts:

• On Friday, June 16th, Martin Court acquired 11 shares of Victrex stock. The stock was purchased at an average price of GBX 1,457 ($19.05) per share, for a total transaction of £160.27 ($209.56).
• On Tuesday, May 16th, Martin Court acquired 600 shares of Victrex stock. The stock was purchased at an average price of GBX 1,530 ($20.01) per share, for a total transaction of £9,180 ($12,003.14).

Victrex Stock Up 1.5 %

LON:VCT opened at GBX 1,515 ($19.81) on Wednesday. Victrex plc has a 12-month low of GBX 1,320 ($17.26) and a 12-month high of GBX 1,953.15 ($25.54). The company has a quick ratio of 1.99, a current ratio of 3.37 and a debt-to-equity ratio of 9.01. The firm has a market capitalization of £1.32 billion, a P/E ratio of 1,825.30, a P/E/G ratio of 2.45 and a beta of 0.82. The stock’s fifty day simple moving average is GBX 1,496.62 and its 200-day simple moving average is GBX 1,634.69.

Victrex Cuts Dividend

The business also recently declared a dividend, which was paid on Monday, July 3rd. Stockholders of record on Thursday, May 25th were given a GBX 13.42 ($0.18) dividend. The ex-dividend date was Thursday, May 25th. This represents a dividend yield of 0.81%. Victrex’s dividend payout ratio is currently 7,228.92%.

Wall Street Analyst Weigh In

A number of brokerages have commented on VCT. Barclays decreased their price objective on Victrex from GBX 2,090 ($27.33) to GBX 1,880 ($24.58) and set an “overweight” rating on the stock in a research report on Tuesday. Jefferies Financial Group decreased their price objective on Victrex from GBX 1,900 ($24.84) to GBX 1,590 ($20.79) and set a “hold” rating on the stock in a research report on Tuesday, May 23rd. JPMorgan Chase & Co. decreased their price objective on Victrex from GBX 2,050 ($26.80) to GBX 1,750 ($22.88) and set an “overweight” rating on the stock in a research report on Thursday, June 15th. Finally, Berenberg Bank decreased their price objective on Victrex from GBX 2,000 ($26.15) to GBX 1,750 ($22.88) and set a “hold” rating on the stock in a research report on Wednesday, June 7th.

About Victrex

(Get Free Report)

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities.

See Also

• Five stocks we like better than Victrex
• Green Hydrogen Stocks Getting Ready to Deliver Big Gains
• Charles Schwab Gets The Rebound, Time to Buy?
• Is Ebix Inc a Phygital E-Commerce Contender or Pretender?
• 3 Mid-Cap Stocks with Expectations for High-Earnings Growth
• Can Lockheed Martin Fly To A New High In 2023?

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.